Company intelligence / Profile preview

Bionode

West Lafayette, Indiana, United Statesbionode.net ↗

Ownership: Private
Development stage: Preclinical

Overview

Bionode has developed a wearable neuro-modulation device intended as a non-invasive and personalized therapy for reducing intraocular pressure in glaucoma patients. The company had a working prototype and was seeking funding to conduct human clinical trials. The goal was CE Mark approval in Europe and FDA de novo approval in the US. No published results from large-scale human studies were available as of the last update.

Therapeutic areas: GastroenterologyPsychiatryOphthalmologyNephrology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Partnership with an internationally renowned ophthalmologist who owns two ophthalmology institutes in Madrid and Barcelona, Spain.

Beyond the preview

Go deeper on Bionode.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bionode.

Explore the full profile